Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:24 PM
Ignite Modification Date:
2025-12-25 @ 2:18 PM
NCT ID:
NCT02159066
Group ID:
EG001
Title:
Part I: Encorafenib + Binimetinib (Non-naive)
Description:
Participants non-naive to selective BRAF and MEK inhibitors, received encorafenib 450 mg once a day and binimetinib 45 mg twice a day until disease progression or no clinical benefit and initiation of triple combination treatment. No dose reduction below 150 mg for encorafenib and 15 mg for binimetinib was permitted for this study. Treatment cycle for both drugs was defined as 21 days of daily continuous treatment.
Deaths Number Affected:
29
Deaths Number At Risk:
None
Serious Number Affected:
37
Serious Number At Risk:
83
Other Number Affected:
73
Other Number At Risk:
83
Study:
NCT02159066
Results Section:
NCT02159066
Adverse Events Module:
NCT02159066